04 Apr A dubious way to lower drug prices
Richard Parrish
Albany Herald, 4/2/2022 ...
Author: Bayh-Dole Coalition
31 Mar Biden’s looming prescription drug pricing dilemma
Caitlin Owens
Axios, 3/31/2022
Also published in Axios Vitals ...
31 Mar Stolen innovation cuts out taxpayers
Stacey Campfield
The Tennessean, 3/31/2022
Also published in Yahoo News, the Knoxville News-Sentinel, and the Commercial Appeal ...
28 Mar There are unintended costs of federal efforts to control drug prices
Lou Berneman
Patriot-News, 3/26/2022 ...
25 Mar ‘March-in’ battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Zachary Brennan
Endpoints News, 3/25/2022 ...
25 Mar HHS Again Urged To Use March-In Rights To Cut Drug Costs
Britain Eakin
Law360, 3/24/2022 ...
24 Mar Pfizer Covid Pill Targeted in Bid for Biden to Spur Drug Access
Ian Lopez
Bloomberg Law, 3/24/2022 ...
21 Mar Warren Bid to Grab Pfizer Cancer Drug Patents Gets Stern Rebuke
Ian Lopez
Bloomberg Law, 3/18/2022
Also published in Bloomberg Government ...
17 Mar Nearly 100 Organizations and Experts Urge HHS Secretary Xavier Becerra to Reject Xtandi March-In Petition
WASHINGTON, D.C. (March 17, 2022) -- In a letter transmitted today, the Bayh-Dole Coalition and nearly 100 prominent academic and private sector innovation experts and organizations, public policy associations, and legal scholars urged U.S. Department of Health and Human Services Secretary Xavier Becerra to reject the latest march-in petition on prostate cancer drug Xtandi....
